← DocG Medical Summaries
Top Allergy & Immunology Research Papers
1.
7.2
Resensitization of β-Lactams After Negative Initial Standard Evaluation: A Systematic Review and Meta-Analysis.
Overall: This sizable systematic review supports a practical recommendation against routine beta-lactam allergy retesting after a negative evaluation, although heterogeneous evidence and limited direct patient-outcome data reduce certainty.
2.
7.0
Inhaled Salbutamol Versus Placebo for the Treatment of Acute IgE-Mediated Abdominal Pain From Allergic Food Reactions (INSPIRE Trial): A Double-Blind Randomized Trial.
Overall: This small but well-controlled trial reports rapid, patient-important pain relief with an easily deployed treatment, yet its early termination, imprecision, and absent safety reporting make larger confirmation necessary.
3.
6.9
Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy.
Overall: A large randomized trial found that sustained high maternal egg and peanut intake was safe but did not prevent infant egg or peanut allergy, supporting avoidance of this burdensome preventive recommendation.
4.
6.9
First-trimester asthma controller medication use and major congenital malformation risk in offspring of women with asthma: A nationwide population-based cohort study.
Overall: This large US observational cohort addresses an important pregnancy-safety question using patient-important outcomes, but incomplete quantitative reporting and a residual safety signal limit confidence and practice-changing impact.
5.
6.8
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Overall: This small uncontrolled extension provides clinically relevant evidence that oral sebetralstat is practical and well tolerated for breakthrough hereditary angioedema attacks, but comparative efficacy and precise net benefit remain uncertain.
6.
6.8
Tezepelumab in real-world US patients with severe asthma across phenotypes and underrepresented populations: the phase 4 PASSAGE study.
Overall: This US phase 4 study reports large, patient-important improvements across diverse severe-asthma populations, but its uncontrolled pre-post design substantially limits causal certainty.
7.
6.7
Early and Sustained Efficacy of Depemokimab in Type 2 Asthma: A Pooled Analysis of the SWIFT-1/-2 Studies.
Overall: Depemokimab produced sustained improvements in exacerbations and several patient-centered outcomes with convenient twice-yearly dosing, but incomplete absolute-effect and safety reporting and the specialty-oriented nature of biologic asthma care limit immediate US primary-care impact.
8.
6.6
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome.
Overall: Small uncontrolled studies provide encouraging long-term evidence of major reductions in severe infections and bleeding, but treatment is complex and the estimates remain vulnerable to bias.
9.
6.6
Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis.
Overall: Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis provides a rigorous and clinically relevant synthesis, but its largely observational findings offer limited direct evidence that risk-based interventions improve patient outcomes.
10.
6.5
Second-Generation H1-Antihistamines Do Not Alter Dementia Risk in Type 2 Inflammatory Diseases: A Target Trial Emulation Using Real-World Data.
Overall: This large observational analysis offers clinically relevant reassurance about dementia risk from second-generation antihistamines, but residual confounding and the absence of quantitative effect estimates limit its ability to establish net benefit or independently change practice.
Score Guide:
9-10 Exceptional
7-8 Strong
5-6 Moderate
3-4 Weak
1-2 Poor
Top papers in other specialties
Emergency MedicineFamily Medicine / General Practice / Primary CareInternal MedicineCardiologyDermatologyEndocrinologyGastroenterologyGeneticsGeriatricsHematologyInfectious DiseaseCritical CareNephrologyNeurologyObesityOccupational & Environmental HealthOncologyPain MedicinePalliative & Supportive CarePhysical Medicine & RehabilitationPsychiatryPublic HealthPulmonology/RespirologyRheumatologyObstetrics & GynecologyPediatricsAnesthesiologyOphthalmologyOtolaryngology (ENT)OrthopedicsUrologySurgery (Other)Sports MedicineAddiction Medicine